Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases
2011
Abstract
Monitoring of infliximab pharmacokinetics and regular monitoring of antibodies to infliximab may contribute ot the prediction of disease development and biological treatment efectiveness.